Multiparameter Longitudinal Imaging of Immune Cell Activity in Chimeric Antigen Receptor T Cell and Checkpoint Blockade Therapies-Reference-Cited by-同舟云学术

Multiparameter Longitudinal Imaging of Immune Cell Activity in Chimeric Antigen Receptor T Cell and Checkpoint Blockade Therapies

Published:2022-05-12 Issue:5 Volume:8 Page:590-602
ISSN:2374-7943
Container-title:ACS Central Science
language:en
Short-container-title:ACS Cent. Sci.

Author:

Xie Jinghang¹,El Rami Fadi¹,Zhou Kaixiang¹,Simonetta Federico²,Chen Zixin,Zheng Xianchuang¹,Chen Min¹^ORCID,Balakrishnan Preethi B.¹,Dai Sheng-Yao¹,Murty Surya¹,Alam Israt S.¹,Baker Jeanette²,Negrin Robert S.²,Gambhir Sanjiv S.¹^ORCID,Rao Jianghong¹^ORCID

Affiliation:

1. Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, California 94305, United States

2. Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University Medical Center, Stanford, California 94305, United States

Funder

National Cancer Institute

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acscentsci.2c00142

Reference84 articles.

1. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy

2. Advances in cancer immunotherapy 2019 – latest trends

3. Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma